Potential Efficacy of Nutrient Supplements for Treatment or Prevention of COVID-19

被引:13
作者
Bogan-Brown, Katrina [1 ]
Nkrumah-Elie, Yasmeen [2 ]
Ishtiaq, Yusrah [3 ]
Redpath, Philip [2 ]
Shao, Andrew [3 ]
机构
[1] Brownian Consulting LLC, Hanover, NH USA
[2] ChromaDex Inc, Longmont, CO USA
[3] ChromaDex Inc, 10900 Wilshire Blvd,Ste 600, Los Angeles, CA 90024 USA
关键词
Autoimmune; coronavirus; COVID-19; nicotinamide adenine dinucleotide; oxidative stress; SARS-CoV-2; vitamin B3; vitamin C; vitamin D; zinc;
D O I
10.1080/19390211.2021.1881686
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
COVID-19 (COronaVIrus Disease of 2019), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents an ongoing global health challenge and the deadliest epidemic coronavirus outbreak to date. Early sequencing of the viral genome and knowledge from past coronavirus outbreaks (SARS-CoV-1 and Middle East Respiratory Syndrome, MERS) has led to rapid advances in knowledge of how the virus spreads and infects human hosts. Unfortunately, advancing knowledge has not yet produced a treatment that substantially lowers morbidity or mortality and only recently resulted in the development of a vaccine that prevents severe disease. Mounting evidence supports the notion that dietary supplementation of key essential nutrients may contribute to the body's defenses against infection as well as bolster the body's responses to infection. Evidence supporting the potential beneficial roles of vitamin C, vitamin D, zinc, and B3 vitamins is reviewed here, revealing a combination of basic research elucidating underlying mechanisms of action, preclinical studies and human intervention studies has led to the proliferation of registered clinical trials on COVID-19. Overall, the data suggest this collection of nutrients has a promising impact on reducing the risk and/or severity of COVID-19, although firm conclusions await the results of these trials.
引用
收藏
页码:336 / 365
页数:30
相关论文
共 220 条
[111]  
Kim Yejin, 2013, Immune Netw, V13, P70, DOI 10.4110/in.2013.13.2.70
[112]   Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action [J].
Kollias, Anastasios ;
Kyriakoulis, Konstantinos G. ;
Dimakakos, Evangelos ;
Poulakou, Garyphallia ;
Stergiou, George S. ;
Syrigos, Konstantinos .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (05) :846-847
[113]   Vitamin D and rheumatoid arthritis [J].
Kostoglou-Athanassiou, Ifigenia ;
Athanassiou, Panagiotis ;
Lyraki, Aikaterini ;
Raftakis, Ioannis ;
Antoniadis, Christodoulos .
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2012, 3 (06) :181-187
[114]   Basic leucine zipper transcription factor, ATF-like (BATF) regulates epigenetically and energetically effector CD8 T-cell differentiation via Sirt1 expression [J].
Kuroda, Shoko ;
Yamazaki, Maya ;
Abe, Manabu ;
Sakimura, Kenji ;
Takayanagi, Hiroshi ;
Iwai, Yoshiko .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (36) :14885-14889
[115]   Three Novel Acetylation Sites in the Foxp3 Transcription Factor Regulate the Suppressive Activity of Regulatory T Cells [J].
Kwon, Hye-Sook ;
Lim, Hyung W. ;
Wu, Jessica ;
Schnoelzer, Martina ;
Verdin, Eric ;
Ott, Melanie .
JOURNAL OF IMMUNOLOGY, 2012, 188 (06) :2712-2721
[116]   Symposium 4: Vitamins, infectious and chronic disease during adulthood and aging Vitamin D and respiratory infection in adults [J].
Laaksi, Ilkka .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2012, 71 (01) :90-97
[117]  
Lau F H., 2020, INFECT DIS-NOR, V2020, P20075838, DOI DOI 10.1101/2020.04.24.20075838
[118]   Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab [J].
Laursen, Julie Hejgaard ;
Sondergaard, Helle Bach ;
Sorensen, Per Soelberg ;
Sellebjerg, Finn ;
Oturai, Annette Bang .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 10 :169-173
[119]  
Ledford H, 2020, NATURE, V582, P469, DOI 10.1038/d41586-020-01824-5
[120]  
Lee YH, 2016, CLIN EXP RHEUMATOL, V34, P827